Related Experiment Video
Updated: Jul 7, 2026

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Clinical significance and remission in treating major depressive disorder: parallels between related outcome
Joseph B McGlinchey1, Mark Zimmerman, David C Atkins
1Department of Psychiatry & Human Behavior, Brown University, and Rhode Island Hospital, Providence, RI 02905, USA. JMcGlinchey@lifespan.org
Abstract:
Over the last several years, research has increasingly focused on how to meaningfully characterize treatment outcome, with different terminologies emerging. In the psychotherapy and behavioral assessment research, clinical significance has emerged as the dominant term to describe the assessment of meaningful change due to treatment, whereas for certain psychiatric disorders remission is the term most commonly used to represent the posttreatment assessment of clinically meaningful change. In the treatment of major depressive disorder, these two constructs exhibit parallels in terms of methodology and conceptual themes, though the two lines of outcomes research using these terms have proceeded along largely isolated paths with little acknowledgment of their shared concerns. With a particular focus on the depression literature, this review summarizes the features, concepts, and debates common to both outcome constructs, and suggests future research on these methods that are used to define meaningful treatment outcome.
Related Concept Videos
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Self-Discrepancy and Its Effects
Antidepressant Drugs: MAOIs and Other Agents
Diagnostic and Statistical Manual of Mental Disorders (DSM)
